Mechanism of control of skeletal-muscle contraction by dantrolene sodium.
D000200:Action Potentials / Q000187:drug effects; D000284:Administration, Oral; D000818:Animals; D001001:Anura; D001665:Binding Sites; D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000502:physiology; D002415:Cats; D003620:Dantrolene / Q000008:administration & dosage / Q000494:pharmacology; D003655:Decerebrate State; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D005528:Foot / Q000294:innervation; D006827:Hydantoins / Q000008:administration & dosage / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D007275:Injections, Intravenous; D051379:Mice; D008968:Molecular Conformation; D009046:Motor Neurons / Q000187:drug effects; D009119:Muscle Contraction / Q000187:drug effects*; D009125:Muscle Relaxants, Central / Q000008:administration & dosage / Q000494:pharmacology*; D009132:Muscles / Q000187:drug effects; D009469:Neuromuscular Junction / Q000187:drug effects; D010525:Peripheral Nerves / Q000187:drug effects; D051381:Rats; D012018:Reflex / Q000187:drug effects; D012584:Sciatic Nerve / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects; D014403:Tubocurarine / Q000494:pharmacology
D006827:Hydantoins; D009125:Muscle Relaxants, Central; D002110:Caffeine; D003620:Dantrolene; D002118:Calcium; D014403:Tubocurarine